BioVersys AG (BIOV.SW)

Switzerland · Healthcare · CHF

Key financials

ROE: -61.94%; 2025 (actual)
ROA: -34.76%; 2025 (actual)
Gross Margin: -386.62%; 2025 (actual)
Net Margin: -
Total Assets: CHF 90,636.00K; 2025 (actual)
Net Income: -CHF 21,830.00K; 2025 (actual)
Valuation: CHF 142,851.85K; 2025 (actual)
Stock Price: CHF 24.40; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	-61.94%	-45.39%	-101.76%	-	98.21%	51.87%
Sector average	-19.57%	-18.86%	21.26%	45.9%	27.83%	13.61%
ROA	-34.76%	-27.8%	-44.91%	-90.77%	-	116.88%
Sector average	-4.19%	-6.68%	-24.58%	1.77%	-29.44%	7.73%
Gross Margin	-386.62%	-386.62%	-386.62%	-386.62%

Amounts in CHF (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for BioVersys AG? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	CHF 90,636.00K	CHF 68,568.19K	CHF 44,609.52K	CHF 17,613.30K	-	-
Sector average	CHF 6,583,664.69K	CHF 7,029,775.91K	CHF 7,875,113.17K	CHF 8,842,325.96K	CHF 9,880,548.85K	CHF 10,888,357.41K

Net Income	-CHF 21,830.00K	-CHF 22,126.71K	-CHF 25,416.12K	-CHF 28,238.94K	-CHF 30,818.25K	-CHF 32,766.14K
Sector average	CHF 509,037.80K	CHF 497,738.03K	CHF 567,206.48K	CHF 655,953.18K	CHF 738,044.20K	CHF 795,142.15K

Valuation	CHF 142,851.85K	CHF 144,793.45K	CHF 166,318.80K	CHF 184,790.87K	CHF 201,669.44K	CHF 214,416.13K
Sector average	CHF 12,182,569.70K	CHF 13,169,956.24K	CHF 13,319,586.58K	CHF 13,502,659.68K	CHF 13,728,881.51K	CHF 13,908,079.25K

Stock Price	CHF 24.40	CHF 24.73	CHF 28.41	CHF 31.56	CHF 34.45	CHF 36.62
Sector average	CHF 102.74	CHF 98.77	CHF 102.59	CHF 107.21	CHF 112.19	CHF 115.32